secwatch.observer — SEC 8-K summary
======================================

Issuer:     QSAM Biosciences, Inc. (—)
CIK:        0001310527
Form:       8-K
Filed at:   2024-05-02T23:59:59+00:00
Accession:  0001493152-24-017494
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QSAM Biosciences effects 1-for-2,000 reverse stock split; shares reduced to ~2,127
--------------------------------------------------------------------------------

- Reverse split effective May 2, 2024, converting each 2,000 shares into 1 share.
- Outstanding shares reduced to approximately 2,127 shares from pre-split count.
- Fractional shares compensated with cash (~$13,210.58 per fractional) plus one CVR.
- Reverse split is a condition precedent for pending merger with Telix Pharmaceuticals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1310527/000149315224017494/0001493152-24-017494-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1310527/000149315224017494/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-017494

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer